Phenibut dependence
- PMID: 23391959
- PMCID: PMC3604470
- DOI: 10.1136/bcr-2012-008381
Phenibut dependence
Abstract
Phenibut is a γ-aminobutyric acid (GABA) agonist designed and used as an anxiolytic in Russia. In Western countries, phenibut is not a registered medication but is available through online stores as a supplement. We present a case of a patient who used phenibut to self-medicate anxiety, insomnia and cravings for alcohol. While phenibut was helpful initially, the patient developed dependence including tolerance, significant withdrawal symptoms within 3-4 h of last use and failure to fulfil his roles at work and at home. He finally sought medical assistance in our addictions clinic. We have gradually, over the course of 9 weeks, substituted phenibut with baclofen, which has similar pharmacological properties, and then successfully tapered the patient off baclofen. This required approximately 10 mg of baclofen for each gram of phenibut.
References
-
- Babu KM, McCurdy CR, Boyer E. Opioid receptors and legal highs: salvia divinorum and kratom. Clin Toxicol 2008;46:146–52 - PubMed
-
- Schmidt MM, Sharma A, Schiifano F, et al. “Legal highs” on the net—evaluation of UK-based websites, products and product information. Forensic Sci Int 2011;206:92–7 - PubMed
-
- Watson R. EU drug monitoring agency voices concerns over “legal highs”. BMJ 2010;341:c6491. - PubMed
-
- Magsalin RM, Khan AY. Withdrawal symptoms after internet purchase of phenibut (β-phenyl-γ-aminobutyric acid HCl). J Clin Psychopharmacol 2010;30:648–9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical